Clinical significance of Fas and FasL protein expression in gastric carcinoma and local lymph node tissues

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 10

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

336

HTML

3300

Figures (1-2)

293

Tables (1-4)

212

Sum=4141

Mar 14, 2010 (publication date) through Feb 8, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Mar 14, 2010; 16(10): 1274-1278
Published online Mar 14, 2010. doi: 10.3748/wjg.v16.i10.1274

Table 3 Expression of Fas and FasL in well- and poorly-differentiated gastric carcinoma tissues

^aZ = -2.421, P = 0.015;

^bZ = -2.307, P = 0.021.

Citation: Li Q, Peng J, Li XH, Liu T, Liang QC, Zhang GY. Clinical significance of Fas and FasL protein expression in gastric carcinoma and local lymph node tissues. World J Gastroenterol 2010; 16(10): 1274-1278
URL: https://www.wjgnet.com/1007-9327/full/v16/i10/1274.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i10.1274